Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
60S acidic ribosomal protein P2, encoded by the RPLP2 gene, is a critical component of the eukaryotic ribosomal stalk, a lateral protuberance on the large 60S ribosomal subunit [1, 10]. It forms a pentameric complex with RPLP0 and RPLP1, which is essential for the elongation phase of protein synthesis by recruiting and positioning translation factors at the ribosome's GTPase center [9, 14]. Beyond its canonical role in translation, RPLP2 has been identified as a moonlighting protein involved in various pathological processes, including cancer progression, viral replication, and autoimmune responses [10, 15]. In many malignancies, such as diffuse large B-cell lymphoma (DLBCL) and hepatocellular carcinoma (HCC), RPLP2 is significantly upregulated and correlates with poor prognosis, where it appears to inhibit ferroptosis and promote tumor growth [3, 13]. It also serves as an essential host factor for flaviviruses like Dengue and Zika, facilitating the translation of viral proteins by relieving ribosome pausing [14, 16]. Furthermore, RPLP2 acts as a ligand for Toll-like receptor 4 (TLR4), making it a potential adjuvant for dendritic cell-based cancer vaccines [5, 6]. Therapeutic strategies targeting RPLP2, such as the small molecule Destruxin b or antisense oligonucleotides, are being explored to induce ferroptosis in cancer cells or inhibit viral biogenesis [1, 3].
Inhibition of translation elongation and induction of ferroptosis in cancer cells; TLR4 agonism for immune activation [1, 3, 5]
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 60S acidic ribosomal protein P2 (RPLP2).